Drug Profile
Klebsiella vaccine
Alternative Names: Klebgen BernaLatest Information Update: 09 Jul 2002
Price :
$50
*
At a glance
- Originator Berna Biotech; Punjab University-Chandigarh
- Developer Walter Reed Army Institute of Research
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Klebsiella infections
Most Recent Events
- 09 Jul 2002 Discontinued - Phase-I for Klebsiella infections in USA (IM)
- 08 Oct 1999 No-Development-Reported for Klebsiella infections in India (Unknown route)
- 08 Oct 1999 No-Development-Reported for Klebsiella infections in USA (IM)